Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Forman

Showing results (781-790 of 1,052) with videos related to

Pageof 106
Sort By:
Cancer|April 5, 2024
Body composition and late-occurring chronic health conditions after autologous stem cell transplantation for lymphomaSmith Giri, Christian Harmon, Wendy Landier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?Amrita Krishnan, Auayporn Nademanee, Henry Fung, et al.
Blood|July 2, 2002
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trialMary E D Flowers, Pablo M Parker, Laura J Johnston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantationOlga Sala-Torra, Colleen Hanna, Michael R Loken, et al.
Bone Marrow Transplantation|August 29, 2007
Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndromeR Nakamura, R Rodriguez, J Palmer, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2024
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin LymphomaSwetha Kambhampati Thiruvengadam, Matthew G Mei, Lu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2<sup>+</sup> Breast Cancer Metastasis to the BrainSaul J Priceman, Dileshni Tilakawardane, Brook Jeang, et al.
Journal of Assisted Reproduction and Genetics|March 6, 2019
Early detection of cryostorage tank failure using a weight-based monitoring systemZahava P Michaelson, Sai T Bondalapati, Selma Amrane, et al.
Blood Advances|September 2, 2021
Treatment of allosensitized patients receiving allogeneic transplantationStefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, et al.
Journal of the National Cancer Institute|July 2, 2025
Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphomaRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Pageof 106

Showing results (781-790 of 1,052) with videos related to

Sort By:
Pageof 106
Cancer|April 5, 2024
Body composition and late-occurring chronic health conditions after autologous stem cell transplantation for lymphomaSmith Giri, Christian Harmon, Wendy Landier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?Amrita Krishnan, Auayporn Nademanee, Henry Fung, et al.
Blood|July 2, 2002
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trialMary E D Flowers, Pablo M Parker, Laura J Johnston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantationOlga Sala-Torra, Colleen Hanna, Michael R Loken, et al.
Bone Marrow Transplantation|August 29, 2007
Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndromeR Nakamura, R Rodriguez, J Palmer, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2024
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin LymphomaSwetha Kambhampati Thiruvengadam, Matthew G Mei, Lu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2<sup>+</sup> Breast Cancer Metastasis to the BrainSaul J Priceman, Dileshni Tilakawardane, Brook Jeang, et al.
Journal of Assisted Reproduction and Genetics|March 6, 2019
Early detection of cryostorage tank failure using a weight-based monitoring systemZahava P Michaelson, Sai T Bondalapati, Selma Amrane, et al.
Blood Advances|September 2, 2021
Treatment of allosensitized patients receiving allogeneic transplantationStefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, et al.
Journal of the National Cancer Institute|July 2, 2025
Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphomaRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Pageof 106